Pharmacokinetics of Drugs Administered to Children

ConditionPediatric ALL
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age0-20
SponsorDuke University

About this trial

This is a prospective study of children \<21 years of age with the goal of characterizing the PK of drugs administered per standard of care as prescribed by the treating caregiver.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Children (< 21 years of age) who are receiving understudied drugs of interest per standard of care as prescribed by their treating caregiver

Disqualifiers

Failure to obtain consent/assent (as indicated)

Trial population

Children (\<21 years of age) receiving drugs per standard of care as prescribed by treating caregiver

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Standard of care drug

    Drug

    This study is collecting PK data on children prescribed the following drugs of interest per standard of care: dexmedetomidine, bosentan, furosemide, chlorothiazide, ethacrynic acid, bumetanide, hydromorphone, tacrolimus, ampicillin, gentamicin, caffeine, fentanyl, midazolam, foscarnet, hydroxychloroquine, and moxifloxacin.

Treatment groups

No treatment groups listed

Trial outcomes

Primary outcomes

1

Area under the curve (AUC)

Time frame
Data will be collected throughout the hospital or outpatient stay up to 90 days

Secondary outcomes

1

Maximum concentration (Cmax)

Time frame
Data will be collected throughout the hospital or outpatient stay up to 90 days
2

Time to achieve maximum concentration (Tmax)

Time frame
Data will be collected throughout the hospital or outpatient stay up to 90 days
3

Absorption rate constant (ka)

Time frame
Data will be collected throughout the hospital or outpatient stay up to 90 days
4

Elimination rate constant (kel)

Time frame
Data will be collected throughout the hospital or outpatient stay up to 90 days

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.